Drug Profile
Bezafibrate/chenodeoxycholic acid - Giaconda
Alternative Names: HepacondaLatest Information Update: 15 Jun 2011
Price :
$50
*
At a glance
- Originator Giaconda
- Class Antivirals; Cholic acids; Fibric acid derivatives
- Mechanism of Action Cholesterol 7 alpha hydroxylase inhibitors; Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 08 Jul 2008 Suspended - Phase-II for Hepatitis C in Australia (PO) for further formulation of Hepaconda® and to secure further funding
- 25 Jun 2007 Phase-II clinical trials in Hepatitis C treatment in Australia (PO)
- 09 Mar 2006 Preclinical trials in Hepatitis C treatment in Australia (PO)